Baxter Healthcare Corporation vs NerPharMa S.r.l.: FDA Enforcement Comparison

Baxter Healthcare Corporation has been the subject of 209 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for NerPharMa S.r.l..

Baxter Healthcare Corporation: 0 warning letters, 209 recalls, 0 approval records, 0 Form 483s.

NerPharMa S.r.l.: 0 warning letters, 0 recalls, 0 approval records, 1 Form 483.

Side by side

Baxter Healthcare Corporation — Warning letters0

NerPharMa S.r.l. — Warning letters0

Baxter Healthcare Corporation — Recalls209

NerPharMa S.r.l. — Recalls0

Baxter Healthcare Corporation — Approval records0

NerPharMa S.r.l. — Approval records0

Baxter Healthcare Corporation — Form 483s0

NerPharMa S.r.l. — Form 483s1

Timeline

Baxter Healthcare Corporation

Most recent FDA action: August 19, 2026

Full history →

NerPharMa S.r.l.

Most recent FDA action: June 27, 2025

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Baxter Healthcare Corporation vs NerPharMa S.r.l.: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/baxter-healthcare-corporation-vs-nerpharma-s-r-l

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗